News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Skyepharma PLC Not Hopeful for U.S. Flutiform Approval
June 24, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Britain's SkyePharma said on Thursday the U.S regulator has set tougher than expected demands for approval of its asthma drug Flutiform, which may prove insurmountable.
Twitter
LinkedIn
Facebook
Email
Print
Regulatory
MORE ON THIS TOPIC
FDA
Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay
May 13, 2026
·
1 min read
·
Heather McKenzie
FDA
After ‘most damaging period in FDA history,’ Makary will be hard to replace
May 13, 2026
·
3 min read
·
Tristan Manalac
FDA
FDA’s Makary to resign after Secretary Kennedy signs off
May 12, 2026
·
4 min read
·
Annalee Armstrong
Policy
FDA turns to old drugs to address new diseases, persistent medical needs
May 12, 2026
·
2 min read
·
Tristan Manalac